Loading
Loading
Genomic data analysis for gene discovery and variant interpretation

Time Left To workshop

21
days
10
hours
48
minutes
37
seconds
register now

Welcome to

Genomic data analysis for gene discovery and variant interpretation

This 2-day workshop is aimed at genetics and genomics professionals working on gene discovery and variant interpretation in human genetics within research or clinical diagnostic settings. The course will offer the introduction of both theoretical and practical aspects for the analysis of exome data and interpretation of novel variants. We will also explore the power of consanguinity in allowing novel gene discovery through the analysis of ROH (runs of homozygosity) and the delegates will have the opportunity to apply bioinformatics tools to harness autozygosity in the context of the highly inbred populations from the Middle-East and North-Africa.


The workshop will focus on case-based learning for providing practical skills for exome and SNP data analysis. The delegates are encouraged to apply the learned concepts to their own datasets during the workshop and can present cases of interest if they are previously submitted to the course faculty.

Workshop

Course Contents

  1. NGS principles, WGS vs WES, data metrics, pipelines and principles of filtering. An overview of application to metabolic disease, oncology and rare diseases to allow tutors to present their specialisms?
  2. Workshop focussed on understanding pipelines and analysis strategies (trio, parental, sib pair, singleton).Inheritance-based data filtering for de novo, X-linked or recessive variants versus gene panels. Focus on discovery of homozygous variants. Practical handling of data from fastq to shortlist of variants.
  3. Framework of the ACMG guidelines and databases for data mining (GnomAD, ClinGen and ClinVar, Working through real examples of variant classification and explaining how much weight to give to each piece of evidence (novel, co-segregation in affected family members, protein domains, etc). Examples from rare disease, oncology and students’ variants if submitted well in advance.
  4. SNP arrays, autozygosity mapping, identifying founder variants. Work through real examples of published cases in relevant populations. Discuss the level of evidence needed to confidently publish a new disease gene (2 unrelated families, animal model evidence, functional evidence, etc).
  5. CNV analysis, introduce tools for CNV discovery and databases for CNV interpretation

The Schedule

TEACHING COURSE

Day 1, 8:30 - 9:00 am

REGISTRATION

Day 1, 9:00 - 9:15 am

Welcome

The team
Introduction to the course and ice-breaking session
Welcome
Day 1, 9:15 - 9:45 am

Lecture

Dr Youssef Idaghdour and team
From blood sampling to data analysis: who, what, why?
Workshop I
Day 1, 9:45 - 11:15 am

Workshop I

Dr Tommaso Pippucci and team
From data analysis to a list of rare candidate variants: exome data handling
Day 1, 11:15 am - 11:30 am

Coffee Break

Day 1, 11:30 am - 1:00 pm

Workshop I

Dr Tommaso Pippucci and team
From data analysis to a list of rare candidate variants: exome data handling (cont)
Day 1, 1:00 - 2:00 pm

Prayer & Lunch break

Day 1, 2:00 - 2:30 pm

Lecture

Dr Alberto Magi and team
The challenges of Copy Number Variant (CNV) detection
Day 1, 2:30 - 4:30 pm

Workshop II

Dr Alberto Magi and team
Tools for CNV discovery
Day 1, 4:30 - 4:45 pm

Coffee Break

Day 1, 4:45 - 5:30 pm

Learning reflection time

The team
Q&A session Wrap-up
Day 2, 9:00 - 9:30 am

Lecture

Dr Julia Baptista and team
From a list of rare candidate variants to a diagnosis: tools for variant interpretation
Day 2, 9:30 - 11:30 am

Workshop III

Dr Julia Baptista and team
Variant classification club (bring your own variant!)
Day 2, 11:30 - 11:45 am

Coffee Break

Day 2, 11:45 am - 1:00 pm

Lecture

Dr Youssef Idaghdour and team
Functional validation: functional analysis and a biological insight into disease-causing variants
Day 2, 1:00 - 2:00 pm

Lunch break

Day 2, 2:00 - 4:15 pm

Workshop IV

Dr Youssef Idaghdour and team
RNA sequencing data analysis: functional analysis and a biological insight into disease-causing variants
Day 2, 4:15 - 4:30 pm

Coffee Break

Day 2, 4:30 - 5:30 pm

Q&A session Close

The team

Pricing

Workshop PRICE LIST

Seats are full, registration is closed.
Contact Info
contact us
Level II, Al Nashwan Building , Al Mankhool Road, Bur Dubai
P.O. Box 22252
Venue
THE VENUE

Mohammed Bin Rashid University of Medicine and Health Sciences,
Building 14, Dubai Healthcare City
Makani No. : 31111 91768
Dubai, United Arab Emirates


For registration inquiries, please contact Meeting Minds:

J. Andoni URTIZBEREA, (MD, MSc), aged 59, is a French physician trained in Paris University (1983-1987) and certified in paediatrics and PMR (physical medicine and rehabilitation). After graduating in parallel from the Institut d’Etudes Politiques de Paris in 1987 cum magna laude, he served many years as Medical Director of the AFM-Telethon and then as General Delegate of the Institut de Myologie of Paris (1993-2000). As Scientific Director of the European Neuromuscular Center in the Netherlands and together with AFM’s support (ENMC, 1999-2005), he contributed to the establishment of many worldwide networks in myology, an emerging discipline dedicated to muscle and related disorders (Duchenne muscular dystrophy and spinal muscular atrophy among others). He is currently a part-time clinical myologist in Hendaye, south of France (Hôpital Marin, APHP) and deputy coordinator of the French Neuromuscular Network (FILNEMUS) in Marseilles. Over the past twenty years, he headed various worldwide educational events dedicated to myology (in France, Russia, Latin America and, more recently in the Middle-East). He is a regular visiting professor for the Ministry of Health of Kuwait and a consultant for many pharmas involved in the field. Ideally located at the intersection of industry, patient advocacy groups and academia, his main objective is to raise more awareness about these rare conditions notably in emerging countries and more specifically in the context of novel cutting-edge therapies. Dr. Urtizberea knows quite well the Middle-East, the Indian sub-continent, Russia and Latin America. More recently (2016), and together with Prof. André Megarbané (Beirut, Lebanon), he founded ‘Maladies Orphelines Sans Frontières’ (MOSF), an NGO dedicated to humanitarian relief in the field of rare diseases.